Bristol-Myers Squibb Co. (BMY) News Headlines

▮ More

Date

Headline

1/7/2020 3:05:24 AM Bristol-Myers Squibb Completes Sale Of Manufacturing Facility In Anagni, Italy

1/7/2020 1:35:01 AM Evotec SE Receives $6 Mln Payment From Bristol-Myers Squibb

12/14/2019 5:17:30 AM Bristol-Myers Wins $752 Mln In US Patent Case Against Gilead Sciences

11/21/2019 6:24:19 AM Amgen Completes Acquisition Of Worldwide Rights To Otezla

11/20/2019 4:25:08 PM Bristol-Myers Squibb Completes Acquisition Of Celgene

11/18/2019 7:42:58 AM William Blair Reiterates Bristol-Myers Squibb Co. (BMY) At Outperform

11/16/2019 10:50:19 AM Bristol-Myers Squibb Gets FTC Clearance For Celgene Acquisition

11/1/2019 7:03:57 AM Bristol-Myers Squibb Reports Extension Of Expiration Date For Exchange Offers For Celgene Notes

10/31/2019 7:33:48 AM Bristol-Myers Squibb Boosts FY19 Adj. EPS Outlook - Quick Facts

10/31/2019 7:08:46 AM Bristol-Myers Squibb Q3 Non-GAAP EPS $1.17 Vs $1.09 Last Year

10/23/2019 6:40:24 AM Healthcare Stocks That Hit New Highs ( BNTX, INMD, BMY,...)

9/24/2019 7:37:12 AM Bristol-Myers Squibb Says CHMP Recommends Approval Of Opdivo - Quick Facts

9/24/2019 7:04:02 AM Bristol-Myers Squibb Receives Positive CHMP Opinion On Approval Of Opdivo

9/11/2019 4:19:57 PM Bristol-Myers Squibb Co. (BMY) Declares Quarterly Dividend of $ 0.41, Record Date 10/4/2019

9/11/2019 4:19:31 PM Bristol-Myers Squibb Declares Quarterly Dividend Of $0.41/share, Payable Nov. 1/ Record Oct. 4

9/9/2019 3:00:04 PM Bristol-Myers Squibb To Present At MS Conference; Webcast At 4:15 PM ET

9/5/2019 7:55:45 AM Bristol-Myers' Opdivo Fails To Meet Primary Endpoint In Brain Tumor Study

9/5/2019 7:08:03 AM Bristol-Myers Squibb Updates On Phase 3 Opdivo CheckMate -548 Trial

9/4/2019 7:14:03 AM Bristol-Myers Squibb To Become Limited Partner Of BioMotiv - Quick Facts

9/4/2019 7:02:33 AM BioMotiv And Bristol-Myers Squibb Form Strategic Partnership